These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 33042271)

  • 21. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
    Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
    Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Thomsen-Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability.
    Leão B; Wen X; Duarte HO; Gullo I; Gonçalves G; Pontes P; Castelli C; Diniz F; Mereiter S; Gomes J; Carneiro F; Reis CA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathological classification of colorectal cancer.
    Müller MF; Ibrahim AE; Arends MJ
    Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer.
    Thomas J; Leal A; Overman MJ
    Clin Colorectal Cancer; 2020 Jun; 19(2):73-81. PubMed ID: 32173280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.
    Zheng K; Wan H; Zhang J; Shan G; Chai N; Li D; Fang N; Liu L; Zhang J; Du R; Wu Q; Li X; Zhang C
    J Transl Med; 2020 May; 18(1):215. PubMed ID: 32466784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting microsatellite instability and key biomarkers in colorectal cancer from H&E-stained images: achieving state-of-the-art predictive performance with fewer data using Swin Transformer.
    Guo B; Li X; Yang M; Jonnagaddala J; Zhang H; Xu XS
    J Pathol Clin Res; 2023 May; 9(3):223-235. PubMed ID: 36723384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors.
    Akagi K; Oki E; Taniguchi H; Nakatani K; Aoki D; Kuwata T; Yoshino T
    Cancer Sci; 2021 Mar; 112(3):1105-1113. PubMed ID: 33403729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategic enhancement of immune checkpoint inhibition in refractory Colorectal Cancer: Trends and future prospective.
    Liu N; Shan F; Ma M
    Int Immunopharmacol; 2021 Oct; 99():108017. PubMed ID: 34352568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment.
    Wang Z; Zhao X; Gao C; Gong J; Wang X; Gao J; Li Z; Wang J; Yang B; Wang L; Zhang B; Zhou Y; Wang D; Li X; Bai Y; Li J; Shen L
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33172882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.
    Copija A; Waniczek D; Witkoś A; Walkiewicz K; Nowakowska-Zajdel E
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28067827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression differences among different MSI statuses in colorectal cancer.
    Chen L; Pan X; Hu X; Zhang YH; Wang S; Huang T; Cai YD
    Int J Cancer; 2018 Oct; 143(7):1731-1740. PubMed ID: 29696646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors.
    Gallois C; Landi M; Taieb J; Sroussi M; Saberzadeh-Ardestani B; Cazelles A; Lonardi S; Bergamo F; Intini R; Maddalena G; Pietrantonio F; Corti F; Ambrosini M; Martinetti A; Germani MM; Boccaccio C; Vetere G; Mouillet-Richard S; de Reynies A; Sinicrope FA; Cremolini C; Laurent-Puig P
    Clin Cancer Res; 2023 Sep; 29(18):3771-3778. PubMed ID: 37439810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
    Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weakly supervised annotation-free cancer detection and prediction of genotype in routine histopathology.
    Schrammen PL; Ghaffari Laleh N; Echle A; Truhn D; Schulz V; Brinker TJ; Brenner H; Chang-Claude J; Alwers E; Brobeil A; Kloor M; Heij LR; Jäger D; Trautwein C; Grabsch HI; Quirke P; West NP; Hoffmeister M; Kather JN
    J Pathol; 2022 Jan; 256(1):50-60. PubMed ID: 34561876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
    Danaher P; Warren S; Ong S; Elliott N; Cesano A; Ferree S
    J Immunother Cancer; 2019 Jan; 7(1):15. PubMed ID: 30665466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellite Stable Colorectal Cancer With an Immunogenic Phenotype: Challenges in Diagnosis and Treatment.
    Saller J; Qin D; Felder S; Coppola D
    Clin Colorectal Cancer; 2020 Jun; 19(2):123-131. PubMed ID: 32171644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.